Insider

Daniel O'Day

Insider · Gilead Sciences, Inc. (GILD)

planned sales: $26,426,837

DateTradeSharesAvg. priceValueFiling
November 4, 2026Planned sale 10b5-1 plan112,429—$18,828,485SEC
October 30, 2026Planned sale 10b5-1 plan45,881—$7,598,352SEC

Shown: open-market purchases and sales (Form 4, codes P and S) and notices of planned sales (Form 144), values as filed. Not shown: grants, tax withholding, gifts and option exercises — they are not trades. A disclosed trade does not show how the person rates the company and is not a recommendation.